Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.

@article{Purushotham2005MorbidityAS,
  title={Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.},
  author={Anand David Purushotham and Sara Upponi and Manfred Borislav Klevesath and Lynda Bobrow and Keith Millar and J. P. Myles and Stephen W. Duffy},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2005},
  volume={23 19},
  pages={4312-21}
}
PURPOSE Axillary lymph node dissection (ALND) as part of surgical treatment for patients with breast cancer is associated with significant morbidity. Sentinel lymph node biopsy (SLNB) is a newly developed method of staging the axilla and has the potential to avoid an ALND in lymph node-negative patients, thereby minimizing morbidity. The aim of this study was to investigate physical and psychological morbidity after SLNB in the treatment of early breast cancer in a randomized controlled trial… CONTINUE READING
Highly Influential
This paper has highly influenced 15 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
173 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 173 extracted citations

Similar Papers

Loading similar papers…